Clinical TrialsSearch results
Number of results: 498
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A Phase III, Randomized, Open-Label, Multicenter, Global Study of Volrustomig (MEDI5752) in Combination With Carboplatin Plus Pemetrexed Versus Platinum Plus Pemetrexed or Nivolumab Plus Ipilimumab in Participants With Unresectable Pleural Mesothelioma.
- Unresectable Pleural Mesothelioma
- Hibi Kazushige
- 2023-11-11
Recruiting
- A study on the efficacy and safety of ED1000 in post-prostatectomy patients
- Prostate cancer
- Hinata Nobuyuki
- 2023-11-09
Recruiting
- Inhibitory effect of local administration of Lactobacillus rhamnosus K03 (L8020) on peri-implantitis with suppuration
- Peri-implantitis Active
- Yasuda Keisuke
- 2023-09-13
Recruiting
- Renal Protective Effect of Esaxerenone in CKD Patients with Hypertension
- Chronic kidney disease, Hypertension
- Masaki Takao
- 2023-08-28
Other
- Efficacy and safety of general anesthetics
- Scheduled non-cardiac surgeries under general anesthesia
- Miyoshi Hirotsugu
- 2023-08-17
Recruiting
- Clinical study of the preventive effect of Nobelzin on the development of severe oral mucositis during radiation chemotherapy in oral cancer
- Oral cancer
- Yanamoto Souichi
- 2023-08-10
Recruiting
- Effect of Sacubitril/Valsartan on the recurrence of atrial fibrillation after catheter ablation
- Atrial fibrillation
- Nakano Yukiko
- 2023-08-08
Recruiting
- Phase II study of combination treatment of nivolumab and TM5614 for non-small cell lung cancer (TM-Uprise Study)
- non-small cell lung cancer
- Hattori Noboru
- 2023-07-19
Other
- An Open-Label, Non-Randomized Study to Assess the Safety and Efficacy of Leniolisib in Japanese Patients With Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) Followed By an Open-Label Long-Term Extension
- activated phosphoinositide 3-kinase delta syndrome (APDS)
- Bradt Jason
- 2023-07-04
Recruiting
- Grope of the promotion of appetite using Virtual Reality (VR)
- Loneliness
- Ishinaga Kojiro
- 2023-06-18